Banner Good Samaritan Pharmacy Residency  

Preceptor Publications/Presentations

 

National Presentations 

Buckley MS. 2013 SCCM Annual Congress. Platform Presentation. “A Review of the Guidelines, Existing, and Emerging Data On Managing Serum Sodium Levels”

Buckley MS. 2013 SCCM Annual Congress. Platform Presentation. “Safe Practices for the Distribution and Administration of Drugs”

Buckley MS. 2012 ASHP Midyear Clinical Meeting. Platform Presentation. “Reducing the Stressed Stomach: Optimal Stress Ulcer Prophylaxis Strategies”

Buckley MS. 2011 ASHP Midyear Clinical Meeting. Platform Presentation. “Inhaled Epoprostenol and Milrinone for Pulmonary Arterial Hypertension in ICU patients”

Buckley MS. 2011 ACCP Annual Meeting. Poster Presentation. “Identifying Optimal Dosages of Drugs Requiring Weight-Based Calculations in Over and Underweight Populations”

Buckley MS. 2010 SCCM Annual Congress. Platform Presentation. “Scanning for Medication Error Solutions: Bar-code Technology”

Buckley MS. 2009 SCCM Annual Congress. Platform Presentation. “Is One Sedative Appropriate for Every Cowboy?”

Buckley MS. 2008 SCCM Annual Congress. Poster Presentation. “Cost-Effectiveness of Direct Thrombin Inhibitors in Heparin-induced Thrombocytopenia”

Buckley MS. 2007 ACCP Annual Meeting. Poster Presentation. “Insulin Infusions: Incidence of Hypoglycemic Events and Protocol Deviation”
Buckley MS. 2006 SCCM Annual Congress. Poster Presentation. “An

Evaluation of Medication Errors and Adverse Drug Events in a Pediatric ICU”

Buckley MS. 2004 ACCP Annual Meeting. Poster Presentation. “Prophylactic Amiodarone Following Cardiac Surgery Decreases Atrial Fibrillation Incidence and Hospital Length of Stay: Meta-analysis”

Buckley MS. 2004 ACCP Annual Meeting. Poster Presentation. “Dose-response of Prophylactic Amiodarone for Decreasing Atrial Fibrillation Following Cardiac Surgery: Meta-analysis”

Regional Presentations

Anderson C. 2012 AzPA Health-System Academy Conference. Platform Presentation. “The Role of Inhaled Nitric Oxide in ARDS”

Patel S. 2012 AzPA Health-System Academy Conference. Platform Presentation. “The Use of Thrombolytics for Pulmonary Embolism: 2011 Guideline Update”

David B. 2011 AzPA Health-System Academy Conference. Platform Presentation.  "The Vision of Pharmacy Practice"

Yerondopoulos M. 2011 AzPA Health-System Academy Conference. Platform Presentation. "Implementation of a Pharmacy Anticoagulation Service"

Staib RS, Librodo P. 2011 AzPA Health-System Academy Conference. Platform Presentation. "Anticoagulation: New Agents vs. Current Agents for Atrial Fibrillation and Venous Thromboembolism"

Buckley MS. 2011 AzPA Health System Academy Conference. Platform Presentation. “Controversial Issues in the Management of Heparin-induced Thrombocytopenia”

Staib RS, Librodo P. 13th Annual Cardiac Care Conference (2011). Platform Presentation. "Dabigatran vs. Warfarin for Atrial Fibrillation"

Buckley MS. 2010 AzPA Health System Academy Conference. Platform Presentation.  “The Use of Factor VII for Hemorrhagic Cerebrovascular Events”

Staib RS, Librodo P. 12th Annual Cardiac Care Conference, Phoenix, Ariz. (2010). Platform Presentation.  "Anticoagulants for Venous Thromboembolism and Antiplatelets for Acute Coronary Syndrome"

Peer-Reviewed Journal and Publications

Buckley MS, Anderson CA, Patel SL, Yerondopoulos ML, Wicks LM, Martin MA. Lack of Cross-reactivity of Liposomal Amphotericin B for Aspergillosis in a Patient Experiencing Infusion-related Adverse Events with Amphotericin B Lipid Complex. (Accepted -  Am J Health Syst Pharm)

Buckley MS, Kane-Gill SL, Patel SA. A drug utilization management evaluation of an epoetin use program based on clinical evidence.  (Manuscript submitted to Clin Ther)

Buckley MS, Dzierba AL, Smithburger PL, McAllen KJ, Jordan CJ, Kane-Gill SL. Chlorhexidine for the prevention of nosocomial pneumonia. (Manuscript submitted to J Infect Prev)

Buckley MS, Feldman JP. Inhaled epoprostenol for pulmonary hypertension in critically ill adults. Pharmacotherapy 2010;30:728-40

Pizon AF, Becker CE, Bikin D. The clinical significance of variations in ethanol toxicokinetics. Journal of Medical Toxicology. 2007 Jun;3(2):63-72

Curry SC, Watts DJ, Katz KD, Bikin D, Bukaveckas BL. The effect of single-dose tramadol on oxycodone clearance."Journal of Emergency Medicine. 2007 Nov;33(4):407-11

Curry SC, Pizon AF, Riley BD, Gerkin RD, Bikin DS. Effect of intravenous albumin infusion on brain salicylate concentration. Academy of Emergency Medicine. 2007 Jun;14(6):508-14

Buckley MS, Nolan PE, Slack MK, Tisdale JE, Hilleman DE, Copeland JG. Amiodarone for the prevention of atrial fibrillation following cardiac surgery patients: Meta-analysis of dose response and timing of initiation. Pharmacotherapy 2007;27:360-68

Buckley MS, Erstad BL, Kopp BJ, Theodoureau AD, Priestley G. "Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit." Pediatric Critical Care Medicine 2007;8:145-52

Graeme KA, Curry SC, Bikin DS, Lo Vecchio FA, Brandon TA. The lack of transplacental movement of the cyanide antidote thiosulfate in gravid ewes. Anesthesia & Analgesia. 1999 Dec;89(6):1448-52

Bikin D, Moyer A. An ABBOTTBASE calculation error. Annals of Pharmacotherapy. 1999 Nov;33(11):1230

Dachman WD, Adubofour KO, Bikin DS, Johnson CH, Mullin PD, Winograd M. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. Journal of Infectious Disease. 1994 Mar;169(3):689-91

Invited Peer-reviewed Publications

Buckley MS, Staib RS, Wicks LM. Combination therapy in the management of pulmonary arterial hypertension.  (Accepted - International Journal of Clinical Practice)

Buckley MS. Electrolyte disturbances associated with medications in the critically ill. International J of Intensive Care 2012;19:74-9

Librodo PR, Buckley MS, Luk ME, Bisso A. Chronotherapeutic Drug Delivery. J Infus Nurs 2012;35:329-34

Smithburger PL, Buckley MS, Bejian S, Burenheide K, Kane-Gill SL. A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf 2011;10:871-82

Buckley MS, Wicks LM, Staib RS, Kirejczyk AK, Varker AS, Gibson JJ, Feldman JP. Pharmacokinetic evaluation of ambrisentan. Expert Opinion Drug Metabolic Toxicology 2011;7:371-80

Buckley MS, Feldman JP, Wicks LM, Staib RS. Phosphodiesterase-5 inhibitors in the management of pulmonary arterial hypertension: Safety, tolerability, and efficacy issues. Drug, Healthcare and Patient Safety 2010;2:151–61

Buckley MS, Leblanc J, Cawley M. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Critical Care Medicine 2010;38[Suppl.]:S253-S264

Book Chapters

Buckley MS, Cawley M. Drug-Induced Electrolyte and Acid/Base Disorders. In: Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment. Published by the Society of Critical Care Medicine, Mt. Prospect, IL. 2012

Buckley MS. Electrolytes, Hypertonic Solutions, and Insulin in the Critically Ill. In: High Risk Medications in Special Patient Populations. Published by Springer, New York, N.Y. 2011

Kane-Gill S, Buckley MS. Safe Medication Use in the Critically Ill: Medication Errors and Adverse Drug Events. Pharmacotherapy Self-Assessment Program, 7th Edition. Critical Care/Urgent Care. Published by the American College of Clinical Pharmacy, Kansas City, Mo. 2010

 

Banner Good Samaritan Pharmacy Residency
1111 E. McDowell Road
Phoenix, AZ 85006
Follow Us:  
Facebook IconPinterestTwitter IconYouTube Icon
 
 
 
Jump to top links